GRASSILLI, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 2688
EU - Europa 1727
AS - Asia 247
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 4
SA - Sud America 3
Totale 4680
Nazione #
US - Stati Uniti d'America 2634
DE - Germania 586
IT - Italia 505
SE - Svezia 200
CN - Cina 181
GB - Regno Unito 121
UA - Ucraina 110
DK - Danimarca 58
CA - Canada 54
AT - Austria 37
VN - Vietnam 31
IE - Irlanda 29
FI - Finlandia 19
FR - Francia 19
RU - Federazione Russa 18
TR - Turchia 14
EU - Europa 11
BE - Belgio 10
IN - India 10
RS - Serbia 5
CH - Svizzera 4
HU - Ungheria 3
IR - Iran 3
JP - Giappone 3
MU - Mauritius 3
CL - Cile 2
KR - Corea 2
BG - Bulgaria 1
BR - Brasile 1
HK - Hong Kong 1
NL - Olanda 1
RO - Romania 1
SC - Seychelles 1
SG - Singapore 1
TW - Taiwan 1
Totale 4680
Città #
Ann Arbor 1312
Frankfurt am Main 492
Milan 259
Wilmington 243
Chandler 152
Fairfield 134
Dearborn 114
Jacksonville 97
Houston 91
Woodbridge 91
Ashburn 59
Princeton 57
Cambridge 46
Seattle 44
Mcallen 43
Vienna 35
Nanjing 30
Dublin 29
Guangzhou 24
Altamura 18
Lachine 17
Lawrence 16
Ottawa 16
Segrate 13
Shenyang 13
Shanghai 12
Boardman 11
Nanchang 11
Beijing 10
Brussels 10
Kunming 10
Sacramento 10
San Diego 10
Toronto 10
Auburn Hills 9
Dong Ket 9
Edmonton 9
Lissone 9
Zhengzhou 9
Hebei 8
Tianjin 8
Changsha 7
Fremont 6
Jiaxing 6
Jinan 6
London 6
Halle 5
Los Angeles 5
Napoli 5
Taizhou 5
Turin 5
Andover 4
Bergamo 4
Gavirate 4
Hangzhou 4
Kiev 4
Norwalk 4
Rieti 4
San Mateo 4
Siena 4
Asti 3
Budapest 3
Chions 3
Falls Church 3
Hanoi 3
Magnago 3
Ningbo 3
Pavia 3
Bovisio Masciago 2
Cambiago 2
Cermenate 2
Como 2
Daejeon 2
Fano 2
Gallarate 2
Hefei 2
Montréal 2
Monza 2
Nürnberg 2
Phoenix 2
Rome 2
San Rocco 2
Shaoxing 2
Verona 2
Villa Cortese 2
Aarhus 1
Anaheim 1
Ardabil 1
Arezzo 1
Bari 1
Bologna 1
Boston 1
Brescia 1
Brooklyn 1
Busto Arsizio 1
Cagliari 1
Carate Brianza 1
Casapulla 1
Caserta 1
Cerro Maggiore 1
Totale 3765
Nome #
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation 428
Combinations of a btk inhibitor and fluorouracil for treating cancers 395
Inhibition of GSK3B Bypass Drug Resistance of p53-null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy 389
Pharmaceutical kit for use in the treatment of colon and colorectal cancer 359
GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis 330
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers 323
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype 322
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma 277
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 252
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. 249
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer 230
Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients 162
The antiangiogenic effect of the metronomic combination of 5-Fluorouracil plus vinorelbine is mediated by FAK/AKT pathway downregulation and apoptosis activation 148
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells 136
Btk inhibitors for use in treating chemotherapeutic drug-resistant epithelial tumours 120
Methods for determining the sensitivity or resistance of cancer cells to at least one anticancer drug and/or therapeutically active molecule 119
Isoform of bruton's tyrosine kinase (BTK) protein 114
Modulator compounds of the drug resistance in epithelial tumour cells 109
Modulator compounds of the drug resistance in epithelial tumour cells 108
Isoform of bruton's tyrosine kinase (BTK) protein 107
Isoform of Bruton's tyrosine kinase (BTK) protein 107
Modulator compounds of the drug resistance in epithelial tumour cells 94
NEW ISOFORM OF BRUTON’S TYROSINE KINASE (BTK) PROTEIN 88
Modulator compound of the drug resistance in epithelial tumor cells 71
Emerging actionable targets to treat therapy-resistant colorectal cancers 54
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors 50
Identifying novel actionable targets in colon cancer 41
Editorial: Targeting Bruton Tyrosine Kinase 39
BTK, the new kid on the (oncology) block? 9
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 5
Totale 5235
Categoria #
all - tutte 6942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6942


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201862 0000 00 158 812811
2018/2019361 3316125 1234 3539 41462563
2019/20201067 78628772 95130 13685 10310510212
2020/20211359 6729135128 122135 134139 11014598117
2021/2022639 90839657 2440 2516 18127999
2022/2023964 126288145115 85142 630 0000
Totale 5235